In the Spanish BIOBADASER registry, among 4,706 patients with chronic arthritis, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and AS, 488 had been treated with more than one TNF-α inhibitor over a 4-year period [13]. This evidence concerns the gene TNF and rheumatoid arthritis.